HaystackID

🏥 It starts with a CT scan.

In his latest article, published in Newsline by HaystackID®, Daniel Pelc opens with a radiology report that reads: "Severe facet arthropathy at L4-L5 and L5-S1."

👩‍⚕️ Despite coming from a family of physicians and physicists, Pelc was quietly planning his imminent demise until a engine translated the report into plain English: substantial arthritis in his lower back, nothing alarming.

That gap between clinical language and human understanding, Pelc argued, is the same one healthcare-adjacent counsel now confronts in every malpractice and internal-investigation matter.

💻 And the tools available to bridge it have changed dramatically.

The article traces how the ethical ground beneath the profession has shifted.

✅ Rule 1.1's competence requirement, Comment 8's technology mandate, and ABA Formal Opinion 512 together make one thing clear: technological fluency is no longer optional.

For counsel handling clinical records, malpractice defense, and healthcare investigations, it IS the competence standard.

Among the highlights:

➕ Why adoption is accelerating, with 26% of legal organizations now actively using GenAI and 78% of law firms expecting it to become central to their workflow within five years.
➕ Why "fast is not the same as right," with 979 court decisions in 2026 alone relating to AI-generated case law citations.
➕ The compliance questions GenAI can't answer for you, from HIPAA and Business Associate Agreements to whether AI-assisted work product is discoverable.

💬 According to Pelc, "GenAI outputs must be treated as starting points, not conclusions."

Human expertise—legal and medical—remains the final arbiter.

🤔 Pelc closes with a question worth sitting with: Where does your practice draw the line between AI-assisted competence and AI-dependent malpractice—and who in your organization is responsible for keeping that line current?

🗞️ Read the full article: https://hubs.ly/Q04n_dPv0

When the lawyer needs a translator: GenAI as a bridge between law and medicine Generative AI is bridging law and medicine — reshaping ABA Rule 1.1 competence for malpractice defense, eDiscovery, and healthcare investigations.

🎙️With all of the talk and attention focused on , it would be easy to overlook a topic as pedestrian as cooperation.

After all, shouldn’t advances in AI be able to help parties and their counsel handle discovery without resorting to disagreements over preservation, search, and production issues?

👆 According to leader Phil Favro, the answer is simple: no.

Even as technology transforms how legal teams identify and produce responsive information, the oldest tool in the discovery toolkit—working reasonably with the other side—remains as essential as ever 🤝.

In his latest article on the HaystackID® Insights page, Favro discusses:

✅ Why AI innovation can't replace human cooperation.
Technology helps identify responsive information, but human conduct remains the biggest driver of discovery disputes (and their resolutions).

✅ Lessons from Flexport v. Freightmate AI.
In this case, a federal court criticized counsel on both sides for overreaching in discovery demands, filing premature motions, and failing to meet and confer, noting that "sophisticated, experienced lawyers should know better."

✅ The real costs of intransigence in discovery.
These costs include increased expenses, delayed resolutions, and perhaps most damaging, lost credibility with the court.

Throughout his analysis, Phil provides practical takeaways for cooperative advocacy, including where parties can realistically reach agreement: production formats, privilege logging, search methodologies, and validation procedures.

📝 The bottom line is that cooperation isn't about surrendering merits-based positions; it's about resolving what can be resolved without burning time, money, and goodwill on motion practice.

🖇️ Read the full article: https://hubs.ly/Q04n_9wL0